Paramount Cosmetics (India) Ltd
₹ 36.1
-3.71%
13 Mar
- close price
About
Incorporated in 1985, Paramount Cosmetics (India) Limited is in the business of selling and distribution of cosmetic[1]
Key Points
- Market Cap ₹ 17.5 Cr.
- Current Price ₹ 36.1
- High / Low ₹ 49.0 / 33.2
- Stock P/E 219
- Book Value ₹ 42.1
- Dividend Yield 0.00 %
- ROCE 5.19 %
- ROE 0.15 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.86 times its book value
- Company is expected to give good quarter
- Debtor days have improved from 62.9 to 38.9 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -3.36% over past five years.
- Company has a low return on equity of -1.12% over last 3 years.
- Earnings include an other income of Rs.1.22 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 47.39 | 48.36 | 49.08 | 34.85 | 20.98 | 21.86 | 24.18 | 17.50 | 20.18 | 26.72 | 21.81 | 20.38 | 24.58 | |
| 42.84 | 43.44 | 42.34 | 29.53 | 16.50 | 17.47 | 20.27 | 14.91 | 21.10 | 24.07 | 21.39 | 19.39 | 23.48 | |
| Operating Profit | 4.55 | 4.92 | 6.74 | 5.32 | 4.48 | 4.39 | 3.91 | 2.59 | -0.92 | 2.65 | 0.42 | 0.99 | 1.10 |
| OPM % | 9.60% | 10.17% | 13.73% | 15.27% | 21.35% | 20.08% | 16.17% | 14.80% | -4.56% | 9.92% | 1.93% | 4.86% | 4.48% |
| 0.19 | 0.17 | 0.26 | 0.07 | 0.36 | 0.05 | 0.04 | 1.17 | 4.56 | 0.20 | 2.09 | 1.23 | 1.22 | |
| Interest | 1.88 | 1.92 | 3.03 | 3.23 | 2.82 | 2.50 | 2.25 | 2.31 | 2.35 | 1.70 | 1.74 | 1.60 | 1.59 |
| Depreciation | 0.60 | 0.80 | 2.53 | 2.14 | 1.72 | 1.43 | 1.25 | 1.06 | 0.95 | 0.81 | 0.67 | 0.55 | 0.48 |
| Profit before tax | 2.26 | 2.37 | 1.44 | 0.02 | 0.30 | 0.51 | 0.45 | 0.39 | 0.34 | 0.34 | 0.10 | 0.07 | 0.25 |
| Tax % | 33.63% | 27.00% | 45.14% | 600.00% | 90.00% | 125.49% | 128.89% | 10.26% | 41.18% | 38.24% | 80.00% | 57.14% | |
| 1.50 | 1.74 | 0.80 | -0.09 | 0.04 | -0.13 | -0.12 | 0.34 | 0.20 | 0.21 | 0.02 | 0.03 | 0.08 | |
| EPS in Rs | 3.09 | 3.58 | 1.65 | -0.19 | 0.08 | -0.27 | -0.25 | 0.70 | 0.41 | 0.43 | 0.04 | 0.06 | 0.17 |
| Dividend Payout % | 19.44% | 16.76% | 30.38% | -270.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -8% |
| 5 Years: | -3% |
| 3 Years: | 0% |
| TTM: | 26% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -33% |
| 5 Years: | 18% |
| 3 Years: | 26% |
| TTM: | 147% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 19% |
| 3 Years: | 2% |
| 1 Year: | -10% |
| Return on Equity | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -4% |
| 3 Years: | -1% |
| Last Year: | 0% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.86 | 4.86 | 4.86 | 4.86 | 4.86 | 4.86 | 4.86 | 4.86 | 4.86 | 4.86 | 4.86 | 4.86 | 4.86 |
| Reserves | 17.53 | 18.66 | 19.17 | 16.89 | 16.65 | 14.63 | 14.51 | 14.65 | 14.92 | 15.37 | 15.46 | 15.51 | 15.59 |
| 17.57 | 23.28 | 24.11 | 20.84 | 20.61 | 20.83 | 18.18 | 17.24 | 14.57 | 12.52 | 12.21 | 11.40 | 10.43 | |
| 17.14 | 17.54 | 16.93 | 8.77 | 5.42 | 7.88 | 11.67 | 11.64 | 13.02 | 10.24 | 8.36 | 8.71 | 8.51 | |
| Total Liabilities | 57.10 | 64.34 | 65.07 | 51.36 | 47.54 | 48.20 | 49.22 | 48.39 | 47.37 | 42.99 | 40.89 | 40.48 | 39.39 |
| 13.33 | 25.34 | 23.92 | 22.27 | 20.60 | 19.40 | 18.23 | 17.31 | 16.43 | 15.73 | 14.78 | 14.24 | 14.03 | |
| CWIP | 4.88 | 0.00 | 0.12 | 0.34 | 0.23 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 38.89 | 39.00 | 41.03 | 28.75 | 26.71 | 28.73 | 30.99 | 31.08 | 30.94 | 27.26 | 26.11 | 26.24 | 25.36 | |
| Total Assets | 57.10 | 64.34 | 65.07 | 51.36 | 47.54 | 48.20 | 49.22 | 48.39 | 47.37 | 42.99 | 40.89 | 40.48 | 39.39 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.90 | 7.18 | 0.39 | 6.44 | 3.79 | 4.41 | 4.25 | 2.27 | 0.82 | 3.65 | -0.24 | 1.40 | |
| -4.33 | -8.21 | 1.50 | -0.67 | 0.05 | -0.21 | 0.01 | 0.01 | 4.34 | 0.05 | 2.22 | 0.96 | |
| 3.32 | 1.21 | -3.51 | -5.78 | -3.61 | -4.45 | -4.16 | -2.22 | -5.02 | -4.04 | -2.06 | -2.41 | |
| Net Cash Flow | -0.11 | 0.18 | -1.62 | -0.01 | 0.23 | -0.25 | 0.11 | 0.05 | 0.14 | -0.34 | -0.07 | -0.05 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 85.18 | 85.29 | 77.27 | 29.74 | 2.44 | 53.26 | 100.38 | 126.19 | 134.21 | 85.10 | 64.77 | 38.86 |
| Inventory Days | 157.93 | 197.13 | 254.59 | 364.78 | 1,472.85 | 1,345.79 | 1,030.13 | 1,959.47 | 874.23 | 395.64 | 399.38 | 594.07 |
| Days Payable | 119.07 | 140.01 | 147.13 | 109.26 | 136.23 | 266.23 | 171.69 | 411.83 | 227.83 | 78.11 | 48.75 | 50.90 |
| Cash Conversion Cycle | 124.05 | 142.41 | 184.73 | 285.27 | 1,339.06 | 1,132.83 | 958.82 | 1,673.83 | 780.61 | 402.64 | 415.40 | 582.03 |
| Working Capital Days | 88.65 | 59.25 | 76.53 | 55.82 | 94.29 | 13.36 | 6.19 | 50.47 | 86.46 | 74.72 | 148.11 | 152.41 |
| ROCE % | 11.11% | 9.89% | 9.44% | 7.16% | 7.37% | 7.30% | 6.93% | 7.27% | -4.84% | 6.08% | 2.51% | 5.19% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales of Cosmetic Products (Manufactured) INR Lakhs |
|
|||||||||||
| Number of Permanent Employees Count |
||||||||||||
| Sales of Stock-in-Trade (Trading Model) INR Lakhs |
||||||||||||
| Trade Receivables Turnover Ratio Ratio |
||||||||||||
| Capacity Utilization (Pandemic period) % |
||||||||||||
| Finished Goods Inventory Holding Days |
||||||||||||
| Operating Cycle Days |
||||||||||||
Requires Premium
Requires Premium
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Credit Rating
6 Mar - CARE reaffirmed Long-term CARE B (Stable) and Short-term CARE A4 for Rs.8.53 crore facilities on Feb 23, 2026.
-
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
16 Feb - EGM passed three special resolutions Feb 13: exempt MD from rotation; approve related-party fixed asset sale; authorize property sale.
-
Sale Of Property To Related Party Or Any Other Person And Authorization To Managing Director
13 Feb - Shareholders approved MD exemption; related-party asset sale approx. ₹3.00 Cr and another asset ~₹0.60 Cr on Feb 13, 2026.
-
Approval Of Related Party Transactions.
13 Feb - EGM 13-Feb-2026: MD exempted from rotation; related-party asset sales ~₹3.6 Cr (₹3.0 Cr + ₹0.6 Cr).
-
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
13 Feb - EGM Feb 13, 2026: AOA amended exempting MD from rotation; RPT sale ~Rs3Cr and asset disposal ~Rs60L.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2]
PCIL, the flagship company of the Paramount group, is
engaged in the manufacturing of beauty and personal care products like bindi, kumkum, kajal, deodorants, etc. The co. is known for its flagship brand,
Shilpa bindis, along with various other brands, including Sunspot (sticker bindis and liquid kumkum),
Kromme (instant eye shadow applicator)
and Instinct (men’s deodorants), etc. Currently, PCIL is into trading, selling & distribution of cosmetics like Bindi, Kumkum, Kajal, and other products
through selling & distribution agreements.